E699-1525 Screening compound: 1-[(1-cyclobutanecarbonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide

E699-1525 Screening compound: 1-[(1-cyclobutanecarbonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide
E699-1525 Screening compound: 1-[(1-cyclobutanecarbonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E699-1525
1-[(1-cyclobutanecarbonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E699-1525

Molecular Formula

C26H32N4O4S (C26 H32 N4 O4 S)

Compound Name

1-[(1-cyclobutanecarbonyl-2-methyl-2,3-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide

IUPAC name

1-[(1-cyclobutanecarbonyl-2-methyl-23-dihydro-1H-indol-5-yl)sulfonyl]-N-(3-methylpyridin-2-yl)piperidine-4-carboxamide

SMILES

CC(C1)N(C(C2CCC2)=O)c(cc2)c1cc2S(N(CC1)CCC1C(Nc1ncccc1C)=O)(=O)=O

InChI

InChI=1S/C26H32N4O4S/c1-17-5-4-12-27-24(17)28-25(31)19-10-13-29(14-11-19)35(33,34)22-8-9-23-21(16-22)15-18(2)30(23)26(32)20-6-3-7-20/h4-5,8-9,12,16,18-20H,3,6-7,10-11,13-15H2,1-2H3,(H,27,28,31)/t18-/m1/s1

InChI Key

YMUDVAXJXDNEFG-GOSISDBHSA-N

MDL Number (MFCD)

MFCD14910839

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

496.63

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.892

Distribution Coefficient, logD

2.890

Water Solubility, LogSw

-3.38

Polar Surface Area

79.869

Acid Dissociation Constant (pKa)

9.93

Base Dissociation Constant (pKb)

4.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

E699-1525 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E699-1525 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E699-1525?
Check Price and Availability of E699-1525, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E699-1525 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E699-1525
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E699-1525
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E699-1525 available by request